The investigational combination xanomeline-trospium (KarXT) was effective and well tolerated in individuals with schizophrenia who were experiencing acute psychosis, according to the randomized ...

This week, a hearing at a coroner's court determined the child was suffering from a rare but possibly treatable brain disorder that spurred her behavior After hearing the new evidence, Mia's mom wiped ...

CNN — A British psychiatrist has warned of the mental health impact of political events after a man suffered acute psychotic illness triggered by Brexit. The unidentified middle-aged man was brought ...

The EMERGENT-3 trial, published in the Journal of the American Medical Association Psychiatry, represents a significant advancement in the treatment of schizophrenia, particularly for individuals ...

Results of the EMERGENT-3 trial confirm that the novel investigational antipsychotic xanomeline-trospium (KarXT, Karuna Therapeutics) is effective and well tolerated in adults with schizophrenia ...

In fall 2024, xanomeline trospium chloride (XT) was approved by the U.S. Food and Drug Administration for the treatment of adults with schizophrenia. In an earlier post, we reviewed evidence that this ...

As a psychiatrist and addiction medicine physician, I am surprised that some patients and their families still believe marijuana is a benign and innocuous substance. Over the past several years, I ...